Jun 15, 2026 12:00PM
Jun 9, 2026 04:30PM
Jun 9, 2026 04:30PM
May 13, 2026 05:46AM
May 13, 2026 02:38AM
Mar 2, 2026 06:01AM
Mar 2, 2026 02:00AM Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera
Feb 10, 2026 04:50AM
Feb 10, 2026 03:15AM
Jan 14, 2026 09:00AM
Jan 5, 2026 07:03AM
Jan 5, 2026 07:00AM
Dec 8, 2025 02:54AM
Dec 6, 2025 09:30AM Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
Nov 21, 2025 11:54AM
Nov 7, 2025 11:01AM
Nov 7, 2025 11:00AM
Oct 27, 2025 08:35AM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors
Oct 21, 2025 08:25PM
Sep 8, 2025 03:00AM
Sep 8, 2025 03:00AM
Sep 5, 2025 08:45PM
Sep 5, 2025 08:45PM
Jul 30, 2025 02:41AM
Jul 21, 2025 08:01AM Takeda receives FDA clearance for HYQVIA administration devices
Jul 21, 2025 08:00AM
Jul 14, 2025 05:55AM
Jul 14, 2025 03:00AM
Jun 30, 2025 08:00AM
Jun 3, 2025 10:13AM
Jun 3, 2025 10:12AM
Jun 1, 2025 08:00AM Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Po
May 21, 2025 09:32AM
May 14, 2025 05:10PM
May 14, 2025 05:03PM
May 5, 2025 08:00AM
Mar 3, 2025 06:46AM
Mar 3, 2025 06:45AM
Dec 3, 2024 07:00AM Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics
Nov 7, 2024 07:00AM
Sep 24, 2024 03:00AM
Sep 19, 2024 08:00AM
Aug 7, 2024 06:45AM
Aug 7, 2024 06:45AM
Aug 6, 2024 04:01PM
Jun 22, 2024 10:30PM Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia
Jun 21, 2024 04:00PM

323,566 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All